PROTECTIVE EFFECTS OF BECLOMETHASONE AGAINST INSULIN INDUCED AIRWAY HYPER-REACTIVITY IN GUINEA PIG AND EXPLORATION OF ITS MECHANISM OF ACTION

Authors

  • Mahjabeen Sharif
  • Bushra Tayyaba Khan
  • Mubashir Sharif

Abstract

Background: Inhalational insulin was withdrawn from market in 2007 due to its potential to produce airway hyper-reactivity and bronchoconstriction. So we explored the possible mechanism underlying the acute contractile effects of insulin and protective effects of beclomethasone against insulin induced airway hyper-responsiveness on isolated tracheal smooth muscle of guinea pig in vitro. Methods: This was a laboratory based experimental study. Effects of increasing concentrations of histamine (10-8–10-3 M ), insulin (10-8–10-3 M), insulin pretreated with fixed concentration of indomethacin (10-6 M), and beclomethasone (10-6 M), were studied on isolated tracheal tissue of guinea pig in vitro by constructing cumulative concentration response curves. The tracheal smooth muscle contractions were recorded with Transducer on Four Channel Oscillograph. Results: Histamine and insulin produced a concentration dependent reversible contraction of isolated tracheal muscle of guinea pig. The mean±SEM of maximum amplitudes of contraction with histamine, insulin and insulin pretreated with indomethacin and beclomethasone were 92.5±1.20 mm, 35±1.13 mm, 14.55±0.62 mm and 22±1.154 mm respectively. Beclomethasone shifted the concentration response curve of insulin to the right and downwards. Conclusion: Beclomethasone significantly inhibited the contractile response of insulin which was presumably prostaglandin mediated. So pretreatment of inhaled insulin with beclomethasone may have clinical implication in amelioration of its potential respiratory adverse effects such as bronchoconstriction.Keywords: Histamine, Inhaled insulin, Beclomethasone, Oscillograph, Tracheal muscle

References

Hollander AP, Blonde L, Rowe R, Mehta EA, Milburn LJ, Hershon KS, et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes. Diabetes Care 2010;27:2356–62.

Aparici M, Gomez-Angelats M, Vilella D, Otal R, Carcasona S, Vinals M, et al. Pharmacological characterization of abediterol, a novel inhaled β2- adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models. J Pharmacol Exp Ther 2012;342:497–505.

Heinemann L. New ways of insulin delivery. Int J Clin Pract Suppl 2011;170:31–46.

Rosenstock J, Lorber LD, Gnudi L, Howard PC, Bilheimer WD, Chang CP, et al. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomized trial. Lancet 2010;375:2244–53.

Schaafsma D, Gosens R, Ris JM, Zaagsma J, Meurs H, Nelemans SA. Insulin induces airway smooth muscle contraction. Br J Pharmacol 2007;150:136–42.

Martin JO, Wittlin BM, Anger DB, Martins OD, Sannomiya P, Jancar S. Early phase of allergic airway inflammation in diabetic rats: role of insulin on the signalling pathway and mediators. Cell Physiol Biochem 2010;26:739–48.

Hajare R, Darrhekar MV, Shewale A, Patil V. Evaluation of antihistaminic activity of piper betel leaf in guinea pig. Afr J Pharma Pharmacol 2011;5:113–7.

Kolahian S, Asadi F, Nassiri MS. Reduces inflammatory parameters in airways of diabetic-antigen sensitized guinea pigs. Eur Respir J. 2011;38:1789.

Peterson HA, Korsatko S, Kohler G, Wutte A, Olschewski H, Sparre T, et al. The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma. Br J Clin Pharmacol 2010;69:271–8.

Juskova M, Franova S, Sadlonova V. Acute bronchodilator effect of quercetin in experimental allergic asthma. Bratisi Lek Listy 2011;112:9–12.

Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin. Diabetes Care 2007;29:1818–24.

Jacoby BD, Yost LB, Kumarauel B, Chan-Li Y, Xiao QH, Kuwashima K, et al. Glucocorticoid treatment increases inhibitory M2 muscarinic receptor expression and function in airways. Am J Respir Cell Mol Biol 2001 Apr;24:485-91.

Ma YL, He QY. Study of the role of insulin and insulin receptors in allergic airway inflammation of rats. Zhonghua Yi Xue Za Zhi 2005;85:3419–24.

Amira E, Aziz EA, El Sayed NS, Mehran GL. Anti-asthmatic and anti-allergic effects of thymoquinone on airway-induced hypersensitivity in experimental animals. J Applied Pharma Sci 2011;1(8):109–17.

Dekkers GB, Schaafsma D, Tran T, Zaagsma J, Meurs H. Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype. Am J Respir Cell Mol Biol 2009;41:494–504.

Casaco A, Merino N. Hyperresponsiveness to bronchoconstrictor agents in experimental animals treated with terbutaline and its effects on pancreatic beta cells. J Investig Allergol Clin Immunol 2011;5(3):148–50.

Carpentiere G, Castello F, Marino S. Effect of beclomethasone dipropionate on the bronchial responsiveness to propranolol in asthmatics. Chest 2012;98:263–5.

Terzano C, Morano S, Ceccarelli D, Conti V, Paone G, Petroianni A, et al. Effect of insulin on airway responsiveness in patients with type 2 diabetes mellitus: a cohort study. J Asthma 2009;46:703–7

Downloads

Published

2014-01-01